The timing of transition: where should the line be drawn?

McKenzie, Nicole M.; Gooding, Holly C.; Forman, Sara F.

doi:10.1111/j.1651-2227.2011.02321.x

Cited by 2 publications

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Young adults are also in a period of transition between pediatric and adult-centered models of care [23]. Their rates of health insurance and adherence to preventive health guidelines are the lowest of any age group [24].…”

Section: Adolescent and Young Adulthood As A Critical Window For Cvd mentioning

confidence: 99%

The Unchartered Frontier: Preventive Cardiology Between the Ages of 15 and 35 Years

Gooding

Johnson

2016

Curr Cardiovasc Risk Rep

View full text Add to dashboard Cite

It is well established that atherosclerosis, the pathological basis of cardiovascular disease (CVD), begins in childhood and progresses steadily between the ages of 15 to 35 years. These adolescent and young adult years are also marked by significant physiological, psychological, and sociodemographic changes that impact both CVD risk factor development and CVD prevention and treatment strategies. In this review, we highlight the importance of the primordial prevention of CVD risk factors before they ever occur and the primary prevention of CVD by treating CVD risk factors in this age group. Although the long time to first CVD event for most young people precludes the availability of clinical trials with hard end-points, findings from epidemiology, health psychology, health services research, and clinical trials with surrogate endpoints are discussed to inform an evidence-based approach to CVD prevention in adolescents and young adults.

show abstract

Section: Adolescent and Young Adulthood As A Critical Window For Cvd mentioning

confidence: 99%